link
Bookmarks
Diffuse Marrow Infiltration and Replacement
Brady K. Huang, MDSandra Moore, MDB. J. Manaster, MD, PhD, FACR
To access 4,300 diagnoses written by the world's leading experts in radiology.Try it free - 15 days
0
9
5
0

KEY FACTS

  • Terminology

    • Imaging

      TERMINOLOGY

      • Synonyms

        • Myelodysplasia: formerly known as preleukemia
      • Definitions

        • "Marrow infiltration" and "marrow replacement" refer to amount of cellular vs. adipocytes admixed in lesion
          • Diffuse marrow infiltration: moderately cellular tissue admixed with fat with diffuse bone involvement
            • Regenerated/repopulated/stimulated red marrow
            • Chronic infection
            • HIV/AIDS
            • Storage disorders
            • Early (or treated) phase of myelodysplasia and myeloproliferative disorders
          • Diffuse marrow replacement: densely cellular lesions with no significant adipocytes, distributed diffusely in skeleton
            • Bone metastases
            • Erdheim-Chester disease
            • Multiple myeloma
            • Myelodysplasias: diverse group of hematologic conditions due to ineffective production of myeloid elements
              • Characterized by variety of refractory anemic conditions
            • Myeloproliferative disorders: overproduction of myeloid elements
              • Platelets (essential thrombocytosis)
              • Reticulocytes (polycythemia vera)
              • Fibroblasts/collagen (myelofibrosis)
              • White cells (leukemia)
        • Diffuse marrow infiltration or replacement does not connote benignity or malignancy per se

      IMAGING

      • General Features

        • Radiographic Findings

          • CT Findings

            • MR Findings

              • Imaging Recommendations

                DIFFERENTIAL DIAGNOSIS

                  PATHOLOGY

                  • Staging, Grading, & Classification

                    • Gross Pathologic & Surgical Features

                      CLINICAL ISSUES

                      • Presentation

                        • Natural History & Prognosis

                          • Treatment

                            DIAGNOSTIC CHECKLIST

                            • Consider

                              • Image Interpretation Pearls

                                • Reporting Tips

                                  Selected References

                                  1. Colombo A et al: Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: a cross-sectional whole-body MRI study. Diagnostics (Basel). 11(5), 2021
                                  2. van Vucht N et al: Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation? Skeletal Radiol. 49(8):1269-75, 2020
                                  3. Degnan AJ et al: Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights Imaging. 10(1):70, 2019
                                  4. Messiou C et al: Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. 291(1):5-3, 2019
                                  5. van Vucht N et al: The Dixon technique for MRI of the bone marrow. Skeletal Radiol. 48(12):1861-74, 2019
                                  6. Kumar NM et al: Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities? Skeletal Radiol. 47(12):1661-71, 2018
                                  7. Young JR et al: 18F-FDG PET/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med. 59(5):774-79, 2018
                                  8. Douis H et al: Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine. Eur Radiol. 26(4):932-40, 2016
                                  9. Lecouvet FE: Whole-body MR imaging: musculoskeletal applications. Radiology. 279(2):345-65, 2016
                                  10. Laudemann K et al: Evaluation of bone marrow infiltration in non-neuropathic gaucher disease patients with use of whole-body MRI - a retrospective data analysis. Rofo. 187(12):1093-8, 2015
                                  11. Kohl CA et al: Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience. Skeletal Radiol. 43(8):1079-84, 2014
                                  12. Padhani AR et al: Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol. 200(1):163-70, 2013
                                  13. Moore SL et al: Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol. 198(6):1387-93, 2012
                                  14. Kung JW et al: Bone marrow signal alteration in the extremities. AJR Am J Roentgenol. 196(5):W492-510, 2011
                                  15. Kan JH et al: MRI diagnosis of bone marrow relapse in children with ALL. Pediatr Radiol. 38(1):76-81, 2008
                                  16. Vande Berg, BC: General principles of magnetic resonance imaging of the bone marrow. In Pope T et al: Imaging of the Musculoskeletal System. 1st ed. Elsevier. 1417-30, 2008
                                  17. Steinbach LS: "MRI in the detection of malignant infiltration of bone marrow"--a commentary. AJR Am J Roentgenol. 188(6):1443-5, 2007
                                  18. Tang YM et al: MRI features of bone marrow necrosis. AJR Am J Roentgenol. 188(2):509-14, 2007
                                  19. Dion E et al: Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 238(2):632-9, 2006
                                  20. Moore SL et al: MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol. 185(1):154-9, 2005
                                  21. Zajick DC Jr et al: Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow. Radiology. 237(2):590-6, 2005
                                  22. Maas M et al: Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience. Radiology. 229(2):554-61, 2003
                                  23. Moore SL et al: Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging. Radiographics. 23(6):1389-99, 2003
                                  24. Lecouvet FE et al: Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol. 5(1):43-55, 2001
                                  25. Walker RE et al: Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol. 5(1):5-20, 2001
                                  26. Panicek DM et al: MR imaging of bone Marrow in patients with musculoskeletal tumors. Sarcoma. 3(1):37-41, 1999
                                  27. Vande Berg BC et al: Classification and detection of bone marrow lesions with magnetic resonance imaging. Skeletal Radiol. 27(10):529-45, 1998
                                  28. Vanel D et al: MRI of bone metastases. Eur Radiol. 8(8):1345-51, 1998
                                  29. Wismer GL et al: Chemical shift imaging of bone marrow: preliminary experience. AJR Am J Roentgenol. 145(5):1031-7, 1985
                                  Related Anatomy
                                  Loading...
                                  Related Differential Diagnoses
                                  Loading...
                                  References
                                  Tables

                                  Tables

                                  KEY FACTS

                                  • Terminology

                                    • Imaging

                                      TERMINOLOGY

                                      • Synonyms

                                        • Myelodysplasia: formerly known as preleukemia
                                      • Definitions

                                        • "Marrow infiltration" and "marrow replacement" refer to amount of cellular vs. adipocytes admixed in lesion
                                          • Diffuse marrow infiltration: moderately cellular tissue admixed with fat with diffuse bone involvement
                                            • Regenerated/repopulated/stimulated red marrow
                                            • Chronic infection
                                            • HIV/AIDS
                                            • Storage disorders
                                            • Early (or treated) phase of myelodysplasia and myeloproliferative disorders
                                          • Diffuse marrow replacement: densely cellular lesions with no significant adipocytes, distributed diffusely in skeleton
                                            • Bone metastases
                                            • Erdheim-Chester disease
                                            • Multiple myeloma
                                            • Myelodysplasias: diverse group of hematologic conditions due to ineffective production of myeloid elements
                                              • Characterized by variety of refractory anemic conditions
                                            • Myeloproliferative disorders: overproduction of myeloid elements
                                              • Platelets (essential thrombocytosis)
                                              • Reticulocytes (polycythemia vera)
                                              • Fibroblasts/collagen (myelofibrosis)
                                              • White cells (leukemia)
                                        • Diffuse marrow infiltration or replacement does not connote benignity or malignancy per se

                                      IMAGING

                                      • General Features

                                        • Radiographic Findings

                                          • CT Findings

                                            • MR Findings

                                              • Imaging Recommendations

                                                DIFFERENTIAL DIAGNOSIS

                                                  PATHOLOGY

                                                  • Staging, Grading, & Classification

                                                    • Gross Pathologic & Surgical Features

                                                      CLINICAL ISSUES

                                                      • Presentation

                                                        • Natural History & Prognosis

                                                          • Treatment

                                                            DIAGNOSTIC CHECKLIST

                                                            • Consider

                                                              • Image Interpretation Pearls

                                                                • Reporting Tips

                                                                  Selected References

                                                                  1. Colombo A et al: Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: a cross-sectional whole-body MRI study. Diagnostics (Basel). 11(5), 2021
                                                                  2. van Vucht N et al: Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation? Skeletal Radiol. 49(8):1269-75, 2020
                                                                  3. Degnan AJ et al: Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement. Insights Imaging. 10(1):70, 2019
                                                                  4. Messiou C et al: Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. 291(1):5-3, 2019
                                                                  5. van Vucht N et al: The Dixon technique for MRI of the bone marrow. Skeletal Radiol. 48(12):1861-74, 2019
                                                                  6. Kumar NM et al: Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities? Skeletal Radiol. 47(12):1661-71, 2018
                                                                  7. Young JR et al: 18F-FDG PET/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med. 59(5):774-79, 2018
                                                                  8. Douis H et al: Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine. Eur Radiol. 26(4):932-40, 2016
                                                                  9. Lecouvet FE: Whole-body MR imaging: musculoskeletal applications. Radiology. 279(2):345-65, 2016
                                                                  10. Laudemann K et al: Evaluation of bone marrow infiltration in non-neuropathic gaucher disease patients with use of whole-body MRI - a retrospective data analysis. Rofo. 187(12):1093-8, 2015
                                                                  11. Kohl CA et al: Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience. Skeletal Radiol. 43(8):1079-84, 2014
                                                                  12. Padhani AR et al: Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol. 200(1):163-70, 2013
                                                                  13. Moore SL et al: Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol. 198(6):1387-93, 2012
                                                                  14. Kung JW et al: Bone marrow signal alteration in the extremities. AJR Am J Roentgenol. 196(5):W492-510, 2011
                                                                  15. Kan JH et al: MRI diagnosis of bone marrow relapse in children with ALL. Pediatr Radiol. 38(1):76-81, 2008
                                                                  16. Vande Berg, BC: General principles of magnetic resonance imaging of the bone marrow. In Pope T et al: Imaging of the Musculoskeletal System. 1st ed. Elsevier. 1417-30, 2008
                                                                  17. Steinbach LS: "MRI in the detection of malignant infiltration of bone marrow"--a commentary. AJR Am J Roentgenol. 188(6):1443-5, 2007
                                                                  18. Tang YM et al: MRI features of bone marrow necrosis. AJR Am J Roentgenol. 188(2):509-14, 2007
                                                                  19. Dion E et al: Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 238(2):632-9, 2006
                                                                  20. Moore SL et al: MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol. 185(1):154-9, 2005
                                                                  21. Zajick DC Jr et al: Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow. Radiology. 237(2):590-6, 2005
                                                                  22. Maas M et al: Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience. Radiology. 229(2):554-61, 2003
                                                                  23. Moore SL et al: Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging. Radiographics. 23(6):1389-99, 2003
                                                                  24. Lecouvet FE et al: Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol. 5(1):43-55, 2001
                                                                  25. Walker RE et al: Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol. 5(1):5-20, 2001
                                                                  26. Panicek DM et al: MR imaging of bone Marrow in patients with musculoskeletal tumors. Sarcoma. 3(1):37-41, 1999
                                                                  27. Vande Berg BC et al: Classification and detection of bone marrow lesions with magnetic resonance imaging. Skeletal Radiol. 27(10):529-45, 1998
                                                                  28. Vanel D et al: MRI of bone metastases. Eur Radiol. 8(8):1345-51, 1998
                                                                  29. Wismer GL et al: Chemical shift imaging of bone marrow: preliminary experience. AJR Am J Roentgenol. 145(5):1031-7, 1985